Direct Digital Holdings (DRCT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Jun, 2026Executive summary
Amendment corrects voting rights to include Series A Convertible Preferred Stock, reflecting 27,077 shares outstanding as of the record date, representing 53,219 votes.
Annual meeting scheduled for July 31, 2026, with a record date of June 18, 2026, for voting eligibility.
No changes to the proposals to be acted upon at the annual meeting; all other proxy statement items remain unchanged.
Voting matters and shareholder proposals
Holders of Class A, Class B Common Stock, and Series A Convertible Preferred Stock (on an as-converted basis) are entitled to vote.
Each Class A and Class B share has one vote; Series A Convertible Preferred Stock votes as if converted to Class A shares.
739,531 Class A, 42,160 Class B, and 27,077 Series A Convertible Preferred shares outstanding as of the record date.
Board of directors and corporate governance
All Class B Common Stock is held by Direct Digital Management, LLC, indirectly owned by the Chairman/CEO and President.
Directors, executive officers, and 5% beneficial owners collectively control 6.3% of total voting power.
Latest events from Direct Digital Holdings
- Q2 2026 revenue fell 23% year-over-year, but core business excluding DSP grew and margins held steady.DRCT
Q2 2026 - Directors were elected, auditor ratified, and incentive plan shares increased by 1.2 million.DRCT
AGM 2026 - Adtech platform targets middle market growth with new solutions and financial restructuring.DRCT
Investor presentation - Shareholders will vote on director elections, auditor ratification, and a major incentive plan amendment.DRCT
Proxy filing - Up to $50M in equity funding via Roth Principal Investments, with dilution and Nasdaq risks.DRCT
Registration filing - Revenue fell 18% but margins and losses improved, with ongoing liquidity and Nasdaq risks.DRCT
Q1 2026 - Up to $50M in equity funding is available, but with major dilution and Nasdaq compliance risks.DRCT
Registration filing - Buy-side revenue surged 28% in Q4 as strategic shifts and capital actions target 2026 recovery.DRCT
Q4 2025 - Executing a turnaround with direct DSP integrations after a 2024 revenue dip.DRCT
Investor presentation